Pediatrix Medical Group (NYSE:MD) Price Target Raised to $18.00

Pediatrix Medical Group (NYSE:MD) had its price objective increased by Truist Financial from $15.00 to $18.00 in a research note published on Friday morning,Benzinga reports. Truist Financial currently has a hold rating on the stock.

A number of other research firms have also weighed in on MD. UBS Group increased their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a report on Tuesday, November 5th. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Jefferies Financial Group lifted their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Macquarie started coverage on Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average price target of $17.08.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $15.57 on Friday. The stock has a 50 day moving average of $13.89 and a 200 day moving average of $13.01. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of -12.97, a PEG ratio of 1.74 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. As a group, sell-side analysts forecast that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several hedge funds have recently added to or reduced their stakes in MD. Pacer Advisors Inc. purchased a new position in shares of Pediatrix Medical Group during the fourth quarter worth approximately $35,492,000. American Century Companies Inc. lifted its holdings in shares of Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after purchasing an additional 1,500,485 shares during the last quarter. Oberweis Asset Management Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $6,122,000. Renaissance Technologies LLC lifted its stake in shares of Pediatrix Medical Group by 117.4% during the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock worth $11,005,000 after buying an additional 453,000 shares during the period. Finally, Boston Partners increased its holdings in shares of Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after purchasing an additional 393,600 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.